You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康華生物(300841.SZ):一曜集團擬轉讓一曜生物20%股權
格隆匯 09-07 09:03

格隆匯9月7日丨康華生物(300841.SZ)公佈,公司於2020年7月以自有資金2800萬元收購了一曜生物10.00%股權,成為一曜生物股東。近日,公司從公開渠道及一曜集團向公司提交的《關於一曜集團擬轉讓其持有廣西一曜20%股權事宜的報告》知悉,一曜生物的股東一曜集團擬將其持有的一曜生物20%股權作價5600萬元對外轉讓給奧聯電子(300585.SZ)

奧聯電子實際控制人系錢明飛,錢明飛通過平潭盈科盛道創業投資合夥企業(有限合夥)、淄博泰格盈科創業投資中心(有限合夥)間接持有公司5%以上股份,根據《深圳證券交易所創業板股票上市規則(2020年修訂)》等有關法律法規的規定,奧聯電子系公司關聯方。

截至2020年9月6日,公司尚未收到一曜集團提供的股權轉讓事宜的書面通知。根據《公司法》和一曜生物公司章程的規定,一曜集團應向公司提供股權轉讓書面通知,同時公司對上述轉讓的股權享有同等條件下的優先購買權。公司若放棄該次股權轉讓的優先購買權將構成關聯交易並與關聯方形成共同投資關係。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account